Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?

por Luce, Mathilde, Bouchara, Anais, Pastural, Myriam, Granjon, Samuel, Szelag, Jean Christophe, Laville, Maurice, Arkouche, Walid, Fouque, Denis, Soulage, Christophe O., Koppe, Laetitia
Publicado 2018

Safety and Efficacy of Short Daily Hemodialysis with Physidia S(3) System: Clinical Performance Assessment during the Training Period

por Fessi, Hafedh, Szelag, Jean-Christophe, Courivaud, Cécile, Nicoud, Philippe, Aguilera, Didier, Gilbert, Olivia, Morena, Marion, Thomas, Michel, Canaud, Bernard, Cristol, Jean-Paul
Publicado 2022